Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3413]
News [7789]
Articles [63]
Editorials [9]
Conferences [208]
elearning [49]
ESMO 2017: Prostate cancer highlights
Prof Karim Fizazi, Prof Stephane Oudard, Dr Bertrand Tombal & Prof Maria De...
ESMO 2017: Prostate cancer highlights ( Prof Karim Fizazi, Prof Stephane Oudard, Dr Bertrand Tombal & Prof Maria De Santis )
10 Sep 2017
The METRIC trial of trametinib, five years on
Prof Dirk Schadendorf - Essen University Hospital, Essen, Germany
The METRIC trial of trametinib, five years on ( Prof Dirk Schadendorf - Essen University Hospital, Essen, Germany )
10 Sep 2017
Treatment choices in thyroid cancer
Prof Makoto Tahara - National Cancer Center Hospital East, Kashiwanoha, Japan
Treatment choices in thyroid cancer ( Prof Makoto Tahara - National Cancer Center Hospital East, Kashiwanoha, Japan )
10 Sep 2017
Clinical advances in treating colorectal cancer
Prof Michael Geißler - Klinikum Esslingen, Esslingen am Neckar, Germany
Clinical advances in treating colorectal cancer ( Prof Michael Geißler - Klinikum Esslingen, Esslingen am Neckar, Germany )
10 Sep 2017
ABP 980, a biosimilar antibody for trastuzumab
Dr Richard Markus - Amgen, Conejo Valley, USA
ABP 980, a biosimilar antibody for trastuzumab ( Dr Richard Markus - Amgen, Conejo Valley, USA )
10 Sep 2017
New strategies in melanoma care
Dr Alexander van Akkooi - Netherlands Cancer Institute, Amsterdam, Netherlands
New strategies in melanoma care ( Dr Alexander van Akkooi - Netherlands Cancer Institute, Amsterdam, Netherlands )
10 Sep 2017
Abemaciclib for advanced breast cancer
Dr Angelo Di Leo - Hospital of Prato, Tuscany, Italy
Abemaciclib for advanced breast cancer ( Dr Angelo Di Leo - Hospital of Prato, Tuscany, Italy )
10 Sep 2017
Comment: MONARCH 3 trial: Abemaciclib for advanced breast cancer
Dr Evandro de Azambuja - Jules Bordet Institute, Brussels, Belgium
Comment: MONARCH 3 trial: Abemaciclib for advanced breast cancer ( Dr Evandro de Azambuja - Jules Bordet Institute, Brussels, Belgium )
10 Sep 2017
CheckMate 214: nivolumab ipilimumab vs sunitinib for advanced or metastatic...
Dr Bernard Escudier - Institut Gustave Roussy, Villejuif, France
CheckMate 214: nivolumab ipilimumab vs sunitinib for advanced or metastatic renal cell carcinoma ( Dr Bernard Escudier - Institut Gustave Roussy, Villejuif, France )
10 Sep 2017
RANGE: docetaxel with or without ramucirumab for metastatic urothelial carcinoma
Prof Daniel Petrylak - Yale Cancer Center, New Haven, Connecticut, USA
RANGE: docetaxel with or without ramucirumab for metastatic urothelial carcinoma ( Prof Daniel Petrylak - Yale Cancer Center, New Haven, Connecticut, USA )
10 Sep 2017
Chemotherapy then surgery no better than concomitant chemoradiation for...
Prof Sudeep Gupta - Tata Memorial Hospital, Mumbai, India
Chemotherapy then surgery no better than concomitant chemoradiation for advanced cervical cancer ( Prof Sudeep Gupta - Tata Memorial Hospital, Mumbai, India )
10 Sep 2017
MONARCH 3: Abemaciclib as initial therapy for patients with HR /HER2- advanced...
Dr Angelo Di Leo - Hospital of Prato, Tuscany, Italy
MONARCH 3: Abemaciclib as initial therapy for patients with HR /HER2- advanced breast cancer ( Dr Angelo Di Leo - Hospital of Prato, Tuscany, Italy )
10 Sep 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation